Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes

Register of interests (PDF 151 KB)

Equality Impact Assessment (Guidance development) (PDF 143 KB)

Final draft guidance

Final appraisal document (PDF 257 KB)

Committee papers (PDF 10.97 MB)

Public committee slides (PDF 880 KB)

Final scope (PDF 247 KB)

Final matrix (PDF 266 KB)

NICE's response to comments on the draft scope and provisional matrix monotherapy (PDF 249 KB)

NICE's response to comments on the draft scope and provisional matrix combination therapy (PDF 286 KB)